FREE MEMBERSHIP Includes » ABL Advisor eNews + iData Blasts | JOIN NOW ABLAdvisor Gray ABLAdvisor Blue
Skip Navigation LinksHome / News / Read News


GE Capital Agents $250MM Financing for Amneal Pharmaceuticals

February 11, 2015, 07:13 AM
Filed Under: Pharmaceuticals

GE Capital’s Healthcare Financial Services (HFS) business announced today that it is serving as administrative agent and collateral agent on a $250 million term loan financing for Amneal Pharmaceuticals LLC. This term loan will be pari passu with a previously closed $491 million term loan on which GE Capital is also the administrative agent. GE Capital Markets served as joint bookrunner on both financings.

Headquartered in Bridgewater, N.J., Amneal is a vertically-integrated developer, manufacturer, marketer and distributor of generic pharmaceuticals. It’s among the largest manufacturers of generic pharmaceuticals in the U.S. The proceeds from this financing will be used to fund capital expansion related to manufacturing facilities and a distribution to existing shareholders.

“We value our long-standing relationship with HFS and its deep understanding of our company and our business,” said Rochelle Fuhrmann, Amneal’s CFO. “We’re pleased with its focus and execution as well as its ability to handle the many dynamics that come into play on large financing deals.”

"We are pleased to have completed this financing for Amneal. It’s the sixth transaction we’ve successfully agented for the company over the past several years,” said Al Aria, senior managing director of HFS’ Corporate Finance business. “It further illustrates our ability to combine our pharmaceutical sector expertise with our capital markets capabilities to help rapidly growing companies such as Amneal realize their strategic goals.”

Amneal Pharmaceuticals LLC is a global supplier of generic pharmaceuticals, vertically integrated across the entire supply chain from R&D to finished goods. Since its inception in 2002, Amneal has invested extensively in R&D resources, manufacturing infrastructure, and strategic expansion opportunities — all contributing to significant growth.

GE Capital’s Healthcare Financial Services (HFS) business is one of the most active capital providers in the U.S. healthcare market, deploying approximately $10.5 billion in new commitments to customers via 240+ transactions in 2014.

Week's News

Comments From Our Members

You must be an ABL Advisor member to post comments. Login or Join Now.